Nevus unius lateris
Nevus unius lateris is a rare type of birthmark that is present at birth or appears within the first or second year of life. It is characterized by an extensive network of small, darkly pigmented spots and patches that cover one side of the body and follows a dermatomal distribution.
Characteristics[edit | edit source]
The birthmark is usually unilateral, covering one side of the body, but can also be bilateral in rare cases. The lesions are typically brown to black in color and vary in size. They can be flat or slightly raised and may have a rough or smooth surface. The distribution of the lesions follows the lines of Blaschko, which are invisible lines on the skin that represent the paths of embryonic cell migration.
Etiology[edit | edit source]
The exact cause of Nevus unius lateris is unknown. However, it is believed to be a mosaic disorder, which means it is caused by a mutation that occurs after fertilization and affects only a portion of the body's cells. This mutation is not inherited from the parents and is not likely to be passed on to offspring.
Diagnosis[edit | edit source]
Diagnosis of Nevus unius lateris is primarily based on the characteristic appearance of the lesions and their distribution pattern. In some cases, a skin biopsy may be performed to confirm the diagnosis and rule out other conditions.
Treatment[edit | edit source]
There is no cure for Nevus unius lateris, and treatment is primarily aimed at managing symptoms and preventing complications. This may include the use of topical medications to reduce itching and inflammation, and laser therapy or surgery to remove or reduce the appearance of the lesions.
Prognosis[edit | edit source]
The prognosis for individuals with Nevus unius lateris is generally good. However, there is an increased risk of developing skin cancer, particularly melanoma, in the affected areas. Regular skin examinations are recommended to monitor for changes that may indicate the development of skin cancer.
See also[edit | edit source]
This congenital disorder related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
